Angiocol™, the recombinant α2 NC1 domain from human collagen type-IV inhibits experimental melanoma metatasis in vivo.

被引：0
|
作者：
Prestayko, A
Boutaud, A
Hudson, BG
Jones, D
Roth, J
Kim, J
Brooks, PC
机构：
[1] BioStratum Inc, Durham, NC USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] NYU, Sch Med, New York, NY USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20
引用
收藏
页码：3657S / 3657S
页数：1
相关论文
共 50 条
  • [21] IDENTIFICATION OF A MULTIFUNCTIONAL, CELL-BINDING PEPTIDE SEQUENCE FROM THE A1(NC1) OF TYPE-IV COLLAGEN
    TSILIBARY, EC
    REGER, LA
    VOGEL, AM
    KOLIAKOS, GG
    ANDERSON, SS
    CHARONIS, AS
    ALEGRE, JN
    FURCHT, LT
    JOURNAL OF CELL BIOLOGY, 1990, 111 (04): : 1583 - 1591
  • [22] The NC1 domain of human collagen IV is necessary to initiate triple helix formation
    Söder, S
    Pöschl, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (01) : 276 - 280
  • [23] RADIOIMMUNOASSAY FOR IMMUNOREACTIVE NON-COLLAGENOUS DOMAIN OF TYPE-IV COLLAGEN (NC1) IN SERUM - NORMAL-PREGNANCY AND PREECLAMPSIA
    BIEGLMAYER, C
    HOFER, G
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1989, 27 (03): : 163 - 167
  • [24] Western blotting of NC1 type IV collagen fragments in human plasma
    Werle, E
    Hao, L
    Hasslacher, C
    Fiehn, W
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (07) : 579 - 588
  • [25] THE NC1 DOMAIN OF COLLAGEN TYPE-IV IN NEONATAL DOG GLOMERULAR BASEMENT-MEMBRANES - SIGNIFICANCE IN SAMOYED HEREDITARY GLOMERULOPATHY
    THORNER, P
    BAUMAL, R
    BINNINGTON, A
    VALLI, VEO
    MARRANO, P
    CLARKE, H
    AMERICAN JOURNAL OF PATHOLOGY, 1989, 134 (05): : 1047 - 1054
  • [26] Type IV collagen α6 chain-derived noncollagenous domain 1 (α6(IV)NC1) inhibits angiogenesis and tumor growth
    Mundel, Thomas M.
    Yliniemi, Anna-Maija
    Maeshima, Yohei
    Sugimoto, Hikaru
    Kieran, Mark
    Kalluri, Raghu
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (08) : 1738 - 1744
  • [27] Suppression of tumor cell growth by type iv collagen and a peptide from the NC1 domain of the α3(IV) chain
    Kefalides, NA
    Monboisse, JC
    Bellon, G
    Ohno, N
    Ziaie, Z
    Shahan, TA
    MEDICINA-BUENOS AIRES, 1999, 59 (05) : 553 - 553
  • [28] Recombinant α2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo
    Roth, JM
    Akalu, A
    Zelmanovich, A
    Policarpio, D
    Ng, B
    MacDonald, S
    Formenti, S
    Liebes, L
    Brooks, PC
    AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (03): : 901 - 911
  • [29] extracellular matrix derived human α1 type IV collagen NC1 domain inhibits endothelial and tumor cellular invasion by blocking the activation of matrix metalloproteinase 2
    Akulapalli, Sudhakar
    Boosani, Chandra Shekhar
    CANCER RESEARCH, 2006, 66 (08)
  • [30] THE ALPORT LOCUS ASSOCIATED WITH A DEFECT IN TYPE-IV COLLAGEN NC1 DOMAIN MAPS TO REGION XQ21.3-Q22
    KASHTAN, CE
    SZABO, P
    RICH, S
    MICHAEL, AF
    DEMARTINVILLE, B
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 205 - 205
12345